DE3788004T2 - Verwendung von Tetrahydrocortisol in der Therapie von Glaukom. - Google Patents

Verwendung von Tetrahydrocortisol in der Therapie von Glaukom.

Info

Publication number
DE3788004T2
DE3788004T2 DE87304317T DE3788004T DE3788004T2 DE 3788004 T2 DE3788004 T2 DE 3788004T2 DE 87304317 T DE87304317 T DE 87304317T DE 3788004 T DE3788004 T DE 3788004T DE 3788004 T2 DE3788004 T2 DE 3788004T2
Authority
DE
Germany
Prior art keywords
tetrahydrocortisol
glaucoma
therapy
disclosed
control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE87304317T
Other languages
English (en)
Other versions
DE3788004D1 (de
Inventor
Aaron Louis Southren
Bernard I Weinstein
Gary G Gordon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York Medical College
Original Assignee
New York Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Medical College filed Critical New York Medical College
Publication of DE3788004D1 publication Critical patent/DE3788004D1/de
Application granted granted Critical
Publication of DE3788004T2 publication Critical patent/DE3788004T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE87304317T 1986-05-19 1987-05-15 Verwendung von Tetrahydrocortisol in der Therapie von Glaukom. Expired - Fee Related DE3788004T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/864,610 US4863912A (en) 1986-05-19 1986-05-19 Use of tetrahydrocortisol in glaucoma therapy

Publications (2)

Publication Number Publication Date
DE3788004D1 DE3788004D1 (de) 1993-12-09
DE3788004T2 true DE3788004T2 (de) 1994-04-07

Family

ID=25343665

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87304317T Expired - Fee Related DE3788004T2 (de) 1986-05-19 1987-05-15 Verwendung von Tetrahydrocortisol in der Therapie von Glaukom.

Country Status (8)

Country Link
US (1) US4863912A (de)
EP (1) EP0250088B1 (de)
JP (1) JPH0725679B2 (de)
AT (1) ATE96671T1 (de)
AU (1) AU597660B2 (de)
CA (1) CA1285878C (de)
DE (1) DE3788004T2 (de)
ES (1) ES2059375T3 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4997826A (en) * 1986-05-19 1991-03-05 New York Medical College Tetrahydrocortisol in glaucoma therapy
US4876250A (en) * 1988-10-31 1989-10-24 Alcon Laboratories, Inc. Methods for controlling ocular hypertension with angiostatic steroids
US4945089A (en) * 1987-12-29 1990-07-31 Alcon Laboratories, Inc. Use of tetrahydrocortexolone to prevent elevations in intraocular pressure caused by corticosteroids
US5407926A (en) * 1987-12-29 1995-04-18 Alcon Laboratories, Inc. Ophthalmic composition
US5358943A (en) * 1987-12-29 1994-10-25 Clark Abbot F Use of tetrahydrocortisol to prevent elevations in intraocular pressure caused by corticosteroids
DE68900548D1 (de) * 1988-01-13 1992-01-30 Sanol Arznei Schwarz Gmbh Konzentrierte corticosteroide enthaltende loesungen und verfahren zu deren herstellung.
US5990099A (en) * 1988-10-31 1999-11-23 Alcon Laboratories, Inc. Angiostatic agents and methods and compositions for controlling ocular hypertension
US5371078A (en) * 1988-10-31 1994-12-06 Alcon Laboratories, Inc. Angiostatic steroids and methods and compositions for controlling ocular hypertension
USRE34578E (en) * 1990-05-07 1994-04-05 Lubkin; Virginia Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
FR2680108B1 (fr) * 1991-08-09 1993-11-19 Theramex Sa Laboratoire Nouvelles compositions pharmaceutiques a base de sterouides 6-hydroxymethyles et leur procede d'obtention.
FR2679139B1 (fr) * 1991-07-17 1995-03-17 Theramex Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation.
KR100249555B1 (ko) * 1991-06-18 2000-04-01 루게쥐농 프랑스와 스테로이드를 함유하는 안구용 조성물, 및 녹내장 치료에 이들 조성물을 사용하는 방법
ATE232540T1 (de) * 1991-11-22 2003-02-15 Alcon Lab Inc Angiostatische steroide
AU674681B2 (en) * 1992-04-21 1997-01-09 Schepens Eye Research Institute, Inc., The Ocular androgen therapy in Sjogren's syndrome
US6107289A (en) * 1992-04-21 2000-08-22 The Schepens Eye Research Institute, Inc. Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β
US5376534A (en) * 1993-12-17 1994-12-27 New York Medical College Use of decreased 3-alpha-hydroxysteroid dehydrogenase activity in peripheral lymphocytes or other cells of patients with primary open angle glaucoma as a diagnostic indicator
US5798380A (en) * 1996-02-21 1998-08-25 Wisconsin Alumni Research Foundation Cytoskeletal active agents for glaucoma therapy
US6586425B2 (en) 1996-02-21 2003-07-01 Wisconsin Alumni Research Foundation Cytoskeletal active agents for glaucoma therapy
US5929111A (en) * 1996-12-18 1999-07-27 Alcon Laboratories, Inc. A-seco steroids effective at treating ophthalmic pathological neovascularization and controlling intraocular pressure
US6011023A (en) * 1997-08-27 2000-01-04 Alcon Laboratories, Inc. Angiostatic steroids
GB9914648D0 (en) * 1999-06-24 1999-08-25 Univ Birmingham Control of infra-ocular pressure
US20050239760A1 (en) * 2004-04-23 2005-10-27 Alcon, Inc. Angiostatic agents and methods and compositions for controlling ocular hypertension
US20080125406A1 (en) * 2005-10-14 2008-05-29 Robin Alan L Method for Treating Primary and Secondary Forms of Glaucoma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2783226A (en) * 1955-02-03 1957-02-26 Schering Corp Esters of cortical hormones

Also Published As

Publication number Publication date
ATE96671T1 (de) 1993-11-15
DE3788004D1 (de) 1993-12-09
CA1285878C (en) 1991-07-09
US4863912A (en) 1989-09-05
EP0250088A3 (en) 1990-03-28
JPH0725679B2 (ja) 1995-03-22
ES2059375T3 (es) 1994-11-16
AU7317387A (en) 1987-11-26
EP0250088B1 (de) 1993-11-03
EP0250088A2 (de) 1987-12-23
JPS6322021A (ja) 1988-01-29
AU597660B2 (en) 1990-06-07

Similar Documents

Publication Publication Date Title
ATE96671T1 (de) Verwendung von tetrahydrocortisol in der therapie von glaukom.
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
DK582487D0 (da) Smaapartikel aerosolliposom og liposom-laegemiddelkombinationer til medicinsk anvendelse
ATE133858T1 (de) Verwendung von monoolein bei der behandlung der periodontal- tasche
DE68920374D1 (de) Rechnergestützte Einstellung von Turbinensteuerungen.
DK0445781T3 (da) Anti-glaucomapræparater indeholdende 3-arylcarbonyl-1-aminoalkyl-1H-indol
KR900701323A (ko) 신규한 녹내장 치료용 안과 제제
DK19785A (da) Terapeutisk og/eller praeventiv ophthalmisk oploesning til intraoculaer hypertension og glaucoma
DE3865368D1 (de) Thiophensulfonamide zur behandlung von glaukom.
AU7426487A (en) Method of treating depression using d-fenfluramine
ZA878249B (en) Method and therapeutic compositions for the treatment of bleeding disorders
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DE69017825D1 (de) Heilverfahren von Lebererkrankungen mit Verwendung von Pyrrol-Chinolin-Chinone-Triester und neue Pyrrol-Chinolin-Chinone-Triester.
DE3767175D1 (de) Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen.
DE68912432D1 (de) Pharmazeutische Zusammensetzung, verwendbar bei der Behandlung von Herzgefässerkrankungen.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATE30032T1 (de) N-acylderivate von dipeptiden, ihre herstellung und verwendung bei der therapie von krankheiten und mittel dafuer.
DE68906028T2 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATA273988A (de) Neue verwendung von 11,28-dioxa-4-azatricyclo- (22.3.1.04,9)octacos-18-en-derivaten und sie enthaltende pharmazeutische zubereitungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee